ALAN DUNTON - 11 Dec 2025 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Julio C. Esquivel as Attorney-In-Fact for Alan Dunton
Issuer symbol
OGEN
Transactions as of
11 Dec 2025
Transactions value $
$0
Form type
4
Filing time
15 Dec 2025, 16:25:37 UTC
Previous filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DUNTON ALAN W Director 1990 MAIN STREET, SUITE 750, SARASOTA /s/ Julio C. Esquivel as Attorney-In-Fact for Alan Dunton 15 Dec 2025 0001304773

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Non-Employee Director Option (Right to Buy) Award $0 +125K $0.00 125K 11 Dec 2025 Common Stock 125K $0.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.